Altered myocardial insulin signaling is a hallmark of DCM (Battiprolu et al., 2012; Bugger and Abel, 2014; Jia et al., 2016); however, the molecular mechanisms that have been proposed to contribute to the development of insulin resistance in DCM are not fully understood. Here, INS is linked to familial dilated cardiomyopathy.